Kiri L. Wills

Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability

Lesley D. Schurman, Kiri L. Wills, Blair M Segsworth et al. · Pharmacology Biochemistry and Behavior · 2012 · 62 citations

Cannabis Use, Psychoactive Drug, Addiction +11

CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats

Kiri L. Wills, Kiran Vemuri, Alana Kalmar et al. · Psychopharmacology · 2014 · 28 citations · Full text

Cannabinoid Pharmacology, Molecular Pharmacology, Addiction Medicine +18

Double Dissociation of Monoacylglycerol Lipase Inhibition and CB1 Antagonism in the Central Amygdala, Basolateral Amygdala, and the Interoceptive Insular Cortex on the Affective Properties of Acute Naloxone-Precipitated Morphine Withdrawal in Rats

Kiri L. Wills, Gavin N. Petrie, Geneva Millett et al. · Neuropsychopharmacology · 2015 · 23 citations · Full text

Double Dissociation, Psychoactive Drug, Psychiatry +12

Acute naloxone-precipitated morphine withdrawal elicits nausea-like somatic behaviors in rats in a manner suppressed by N-oleoylglycine

Erin M. Rock, Samantha M. Ayoub, Cheryl L. Limebeer et al. · Psychopharmacology · 2019 · 21 citations

Psychoactive Drug, Behavioral Neuroscience, Addiction +9

Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague–Dawley rats

Gavin N. Petrie, Kiri L. Wills, Fabiana Piscitelli et al. · Psychopharmacology · 2019 · 19 citations

Psychopharmacology, Pharmacotherapy, Experimental Pharmacology +16